Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography.

ABSTRACT: Cardiovascular disease is a leading cause of death among cancer survivors, second only to cancer recurrence or development of new tumors. Cardio-oncology has therefore emerged as a relatively new specialty focused on prevention and management of cardiovascular consequences of cancer therapies. Yet challenges remain regarding precision and accuracy with predicting individuals at highest risk for cardiotoxicity. Barriers such as access to care also limit screening and early diagnosis to improve prognosis. Thus, developing innovative approaches for prediction and early detection of cardiovascular illness in this population is critical. In this review, we provide an overview of the present state of machine learning applications in cardio-oncology. We begin by outlining some factors that should

SUBMITTER: Martinez DS 

PROVIDER: S-EPMC9202996 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature